LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASES

The Lancet

Volumn 321, Issue 8317, 1983, Pages 146-149

  Elomaa, I ^a   Blomqvist, C ^a   Grohn P ^a   Porkka, L ^a   Kairento, A L ^a   Selander, K ^b   Lamberg Allardt, C ^b   Holmstrom T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Endocrine Research Laboratory Kauniainen Finland ^*  (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; ETIDRONIC ACID; MEDRONATE TECHNETIUM TC 99M; PLACEBO;

BONE; BONE METASTASIS; BREAST CANCER; CLINICAL ARTICLE; DRUG THERAPY; HUMAN; HYPERCALCEMIA; THERAPY;

ADULT; AGED; ANALGESICS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; BONE RESORPTION; BREAST NEOPLASMS; CLINICAL TRIALS; CLODRONIC ACID; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCARBONS, CHLORINATED; METHYLENE CHLORIDE; MIDDLE AGED; OSTEOLYSIS; RANDOM ALLOCATION; TIME FACTORS;

EID: 0020666819     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(83)92755-1     Document Type: Article

References (22)

1. Inhibition of osteolytic bone lesions by (3-amino-1-hydroxyprolidene)1, 1-bisphosphonate (A.P.D.)
2. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases
3. Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease
4. Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma
5. Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate
6. Parenteral diphosphonates for treating malignant hypercalcemia
7. IV dichloromethylene diphosphonate in cancer-associated hypercalcemia: A phase I-II evaluation
8. Albumin standards and the measurement of serum albumin with bromcresol green
9. Modifications of a specific assay for hydroxyproline in urine
10. An improved method for quantitative bone scanning
11. Calcium and cancer
12. Hypercalcemia of neoplastic diseases
13. Evidence for the secretion of an osteoclast stimulating factor in myeloma
14. Mechanism of bone destruction in the development of skeletal metastases
15. Direct resorption of bone by human breast cancer cells in vitro
16. Osteoclast activating factor: its role in myeloma and other types of hypercalcaemia of malignancy
17. The effects of diphosphonates on the growth and glycolysis of connective tissue cells in culture
18. Pyrophosphate and diphosphonates in skeletal metabolism: physiological, clinical, and therapeutic aspects
19. Assessment of progression of secondary bone lesions following cancer of the breast or prostate using serial radionuclide imaging
20. Evaluation of sodium etidronate in the treatment of Paget's disease of bone
21. Treatment of Paget's disease with combined calcitonin and diphosphonate (EHDP)
22. Long term effects of dichloromethylene diphosphonate in Paget's disease of bone